Aquestive Therapeutics (AQST): Rentabilitas operasi

Aquestive Corp (AQST) - logo korporat

Aquestive Therapeutics (AQST) does not pay dividends, focusing instead on the defensive epilepsy therapy segment characterized by stable demand. On GURU.Markets, the operating margin curve serves as a confidence indicator, with the metric currently standing at -114.10. Business growth relies on proprietary PharmFilm soluble films, which create an ecosystem for partners, while the company actively expands its network of external contractors to optimize logistics.

AQST - Rasio bathi operasi aquestive.com ing rentang 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis Aquestive Therapeutics (AQST)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Aquestive Pharma
Produk merek Aquestive Corp

Operating margin measures the efficiency of profit generation from core business processes relative to revenue. The operating margin indicator visualizes the dynamics of the alpha factor, where extreme values signal impending volatility. This metric is calculated as the ratio of operating income to sales, reflecting internal profitability. High sensitivity of this indicator is critical for Aquestive Therapeutics (AQST). This is driven by colossal R&D expenditures and strict FDA oversight of proprietary PharmFilm films.

Analisis pesaing Aquestive Therapeutics

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.